Biosimilars Market Value & Industry Overview | Growth Outlook 2027

Executive Summery

This report presents a detailed overview of the Biosimilars Market, highlighting key insights into its market size, share, and growth during the forecast period, i.e., 2022-27. It explores emerging trends, competitive dynamics, and the core drivers reshaping the industry. Backed by solid data and expert analysis, the study offers segment-wise insights and reliable forecasts to guide strategic decisions. With comprehensive market analysis and forward-looking perspectives, this report serves as a practical tool for stakeholders navigating change. Whether you're an investor, policymaker, or business leader, this research helps you stay ahead in the fast-evolving Biosimilars industry landscape.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Download your free sample PDF of the report– https://www.marknteladvisors.com/query/request-sample/biosimilar-market.html

Biosimilars Market Statistics and Key Highlights

The Global Biosimilars Market is projected to grow at a CAGR of around 17% during the forecast period, i.e., 2022-27. 

• Biosimilars market shows steady growth
• Market size expanding due to rising industry demand
• Competitive landscape driven by tech and innovation
• Detailed segment-wise and geography wise share analysis
• Forecast reveals strong trends shaping future outlook

Key Player- Emerging Biosimilars Companies

• Amgen Inc.
• Biocon
• Biogen Inc.
• Celltrion
• Reddy’s Laboratories Ltd
• Eli Lilly and Company
• Hoffmann-La Roche AG
• Merck & Co., Inc.
• Novartis International AG
• Pfizer Inc.
• Samsung Bioepis
• Others

Access Full Market Insights & Key Statistics! https://www.marknteladvisors.com/research-library/biosimilar-market.html

Use your official business email to connect with our team and enjoy full access with priority support.

Biosimilars Market Segmentation

By Product

• Recombinant Non-Glycosylated Proteins
  • Human growth hormones
  • Granulocyte colony-stimulating factor
  • Interferons
  • Insulin
• Recombinant Glycosylated Proteins
  • Erythropoietin
  • Monoclonal Antibodies
  • Follitropin

Among all product types, Recombinant Glycosylated Proteins are expected to dominate the Global Biosimilars Market with the largest share and generate lucrative opportunities for the leading players in the industry during 2022-27.

By Application

• Growth Hormonal Deficiency
• Chronic & Autoimmune Disorders
• Hematology
• Oncology
• Others

By Region

• North America
• South America
• Europe
• Middle East & Africa
• Asia-Pacific

Of all regions globally, Europe is anticipated to dominate the Biosimilars Market with the largest share during 2022-27.

Looking for Global, Regional or country-specific reports on this market?

Visit our website or simply fill out the inquiry form, and our team will reach out with customized insights and support -  https://www.marknteladvisors.com/query/request-customization/biosimilar-market.html

Reasons to Buy This Report

1. Gain comprehensive insights into current market trends and dynamics.
2. Equip your business with data-driven strategies for informed decisions.
3. Identify lucrative market opportunities and strategic growth areas.
4. Analyze competitors to enhance your positioning in the market landscape.
5. Understand geographical trends across diverse markets for better expansion strategies.

Other reports

• https://me-market-research-blog.blogspot.com/2025/06/adult-entertainment-market.html
• https://me-market-research-blog.blogspot.com/2025/06/uae-mammography-market.html

About US:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us:

MarkNtel Advisors LLP

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511 

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

For Sales Enquiries: sales@marknteladvisors.com